Guidance for industry : statistical aspects of the design, analysis, and interpretation of chronic rodent carcinogenicity studies of pharmaceuticals.

Other author Center for Drug Evaluation and Research (U.S.)
Format Electronic
Publication InfoRockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, [2001]
Description1 electronic resource (44 pages)
Supplemental Contenthttps://purl.fdlp.gov/GPO/LPS120137
Subjects

Portion of title Statistical aspects of the design, analysis, and interpretation of chronic rodent carcinogenicity studies of pharmaceuticals
General note"Draft guidance."
General note"Pharm/tox."
General note"May 2001."
Bibliography noteIncludes bibliographical references (p. 38-44).
GPO item number0499-T (online)
Govt. docs number HE 20.4702:C 17/3/DRAFT

Availability

Library Location Call Number Status Item Actions
Electronic Resources Access Content Online ✔ Available